HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Ghosh Selected Research

LFM A12

5/2001Structure-based design of novel anticancer agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Ghosh Research Topics

Disease

32Crohn Disease (Crohn's Disease)
01/2018 - 05/2000
31Infections
11/2020 - 07/2000
30Neoplasms (Cancer)
01/2022 - 01/2001
23Inflammation (Inflammations)
01/2017 - 05/2000
21Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018 - 01/2000
20Ulcerative Colitis
01/2018 - 05/2000
10Type 2 Diabetes Mellitus (MODY)
01/2020 - 11/2005
10Body Weight (Weight, Body)
08/2019 - 03/2001
7Breast Neoplasms (Breast Cancer)
01/2021 - 05/2001
7Carcinoma (Carcinomatosis)
12/2015 - 10/2000
7Necrosis
12/2014 - 01/2004
7Pain (Aches)
03/2014 - 04/2001
6Obesity
04/2015 - 01/2007
5Fibrosis (Cirrhosis)
11/2019 - 10/2012
5Pneumonia (Pneumonitis)
12/2013 - 04/2000
5Hemorrhage
03/2010 - 05/2000
5Carcinogenesis
10/2004 - 03/2001
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2020 - 01/2011
4Colitis
10/2012 - 11/2002
4Ischemia
01/2011 - 03/2000
4Pouchitis
02/2002 - 05/2000
3Hypoxia (Hypoxemia)
01/2021 - 11/2007
3Chronic Hepatitis B
08/2016 - 03/2013
3Neoplasm Metastasis (Metastasis)
12/2015 - 07/2001
3Type 1 Diabetes Mellitus (Autoimmune Diabetes)
04/2015 - 06/2009
3Weight Loss (Weight Reduction)
04/2015 - 02/2010
3Wounds and Injuries (Trauma)
01/2015 - 01/2000
3Lymphoma (Lymphomas)
11/2013 - 05/2001
3Adenocarcinoma
12/2012 - 04/2001
3Insulin Resistance
12/2012 - 05/2011
3Virus Diseases (Viral Diseases)
01/2010 - 07/2001
3Glaucoma
12/2009 - 04/2003
3Osteoarthritis
04/2009 - 02/2007

Drug/Important Bio-Agent (IBA)

20Proteins (Proteins, Gene)FDA Link
01/2018 - 01/2000
12Infliximab (Remicade)FDA Link
05/2017 - 11/2000
9Pharmaceutical PreparationsIBA
03/2014 - 04/2002
9CytokinesIBA
11/2013 - 01/2000
9AntibodiesIBA
09/2013 - 01/2000
8AntigensIBA
01/2016 - 07/2005
7EnzymesIBA
06/2014 - 06/2002
7Interleukin-8 (Interleukin 8)IBA
11/2005 - 02/2001
6Biomarkers (Surrogate Marker)IBA
11/2021 - 02/2009
6Glucose (Dextrose)FDA LinkGeneric
11/2019 - 01/2007
5Adalimumab (Humira)FDA Link
01/2018 - 01/2004
5AntioxidantsIBA
12/2014 - 06/2004
5Peptides (Polypeptides)IBA
02/2010 - 09/2000
5Mesalamine (Mesalazine)FDA LinkGeneric
06/2008 - 11/2001
5Azathioprine (Imuran)FDA LinkGeneric
08/2003 - 05/2000
5SolutionsIBA
11/2002 - 05/2000
5Interleukin-1beta (Interleukin 1 beta)IBA
06/2002 - 02/2001
4VaccinesIBA
11/2020 - 11/2000
4Insulin (Novolin)FDA Link
08/2019 - 05/2011
4Hepatitis B e AntigensIBA
08/2016 - 10/2012
4Peroxidase (Myeloperoxidase)IBA
03/2016 - 08/2002
4LipidsIBA
04/2015 - 08/2001
4PPAR gammaIBA
01/2015 - 11/2005
4Indicators and Reagents (Reagents)IBA
01/2014 - 01/2000
4recombinant FVIIa (rFVIIa)FDA Link
03/2010 - 02/2007
4Certolizumab PegolFDA Link
01/2010 - 01/2004
4NF-kappa B (NF-kB)IBA
05/2009 - 09/2000
4SteroidsIBA
09/2008 - 10/2001
4ElectrolytesIBA
06/2002 - 05/2000
4Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
06/2002 - 05/2000
4Immunoglobulin G (IgG)IBA
06/2002 - 06/2000
3Anti-Bacterial Agents (Antibiotics)IBA
09/2020 - 09/2001
3ErbB Receptors (EGF Receptor)IBA
01/2020 - 01/2001
3Ustekinumab (CNTO 1275)FDA Link
01/2018 - 01/2016
3Antiviral Agents (Antivirals)IBA
11/2016 - 09/2005
3Triglycerides (Triacylglycerol)IBA
04/2015 - 12/2012
3Transcription Factors (Transcription Factor)IBA
01/2015 - 09/2000
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2015 - 09/2006
3Glutathione (Reduced Glutathione)IBA
12/2014 - 07/2001
3QuercetinIBA
04/2013 - 03/2001
3DNA (Deoxyribonucleic Acid)IBA
04/2013 - 11/2005
3NitrogenIBA
02/2012 - 06/2002
3Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
02/2012 - 08/2001
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
02/2012 - 11/2005
3Ribavirin (Virazole)FDA LinkGeneric
08/2011 - 04/2000
3AlbuminsIBA
01/2011 - 06/2000
3CatalaseIBA
12/2010 - 07/2001
3Estrogen ReceptorsIBA
07/2009 - 07/2007
3ImmunosorbentsIBA
12/2008 - 06/2002
3Adrenal Cortex Hormones (Corticosteroids)IBA
09/2008 - 08/2003
3LigandsIBA
09/2006 - 08/2001
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2005 - 03/2001
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2005 - 01/2000
3Glycoproteins (Glycoprotein)IBA
03/2005 - 01/2003
3CarcinogensIBA
10/2004 - 06/2003
3Biological ProductsIBA
06/2003 - 04/2001
3Leukocyte Elastase (Neutrophil Elastase)IBA
10/2001 - 05/2000
3Immunoglobulins (Immunoglobulin)IBA
08/2001 - 01/2000

Therapy/Procedure

48Therapeutics
01/2020 - 04/2000
11Drug Therapy (Chemotherapy)
09/2020 - 06/2000
8Radiotherapy
04/2015 - 10/2000
4Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
01/2021 - 04/2012
3Analgesia
12/2010 - 04/2001
3Decompression
05/2007 - 06/2000
3Enema (Enemas)
06/2005 - 11/2002
3Tracheostomy
05/2005 - 05/2001
3Transplantation
12/2004 - 02/2001